SEPTInvestingStart Free

DARE 8-K: SEC filing

Filed with the SEC on · accession 0001493152-26-051235

DARE filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Daré Bioscience stockholders approved, in accordance with Nasdaq listing rules, the potential future issuance of shares of common stock upon the exercise of outstanding warrants at a special meeting held on November 10, 2026.

For details, click here →How to read a 8-K →

Key details

RegistrantDaré Bioscience, Inc.
President and chief executive officerSabrina Martucci Johnson

✦ Ask GOAX AI about this filing — what it means for DARE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DARE?

Click here

Frequently asked questions

What did DARE file with the SEC on Nov 12, 2026?

DARE filed a 8-K (SEC filing). Daré Bioscience stockholders approved, in accordance with Nasdaq listing rules, the potential future issuance of shares of common stock upon the exercise of outstanding warrants at a special meeting held on November 10, 2026.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other DARE SEC filings

Get alerts when DARE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
DARE overviewDARE analysisDARE newsLatest SEC filings